GP+ Cooperative JV Model — Glossary of Terms

How to use this glossary. Terms are grouped by the sidebar section they appear in within the interactive model. Where a term has a formula or a statutory basis, this is noted in italics or as an inline formula. All dollar figures are Singapore Dollars (SGD) unless stated otherwise.

01 Entity & Legal Structure

GP+ Cooperative The General Practice Plus registered co-operative society. Holds 60% of ClinicCo and exercises sole authority over all clinical governance matters. Registered under the COOP Act.
AUPE Cooperative The labour movement cooperative acting as the capital-investing partner. Holds 40% of ClinicCo. Has no vote on clinical decisions; participates in Tier 2 and Tier 3 governance only.
ClinicCo Pte Ltd The joint venture private limited company incorporated under the Companies Act (Cap. 50). It is the HCSA licensee, employer of clinic staff, and the entity through which profits flow to both cooperatives.
60 / 40 Split The shareholding ratio of ClinicCo: GP+ holds 60%, AUPE holds 40%. GP+ majority is locked — it cannot fall below 50.1% without a Tier 3 special majority vote of both cooperatives.
Branch Model All clinic sites operate as branches under one ClinicCo Pte Ltd. Simpler governance and lower admin cost, but all sites share liability. Each premises still requires a separate HCSA licence.
Franchise Model Each clinic site (or cluster) is a separate Pte Ltd subsidiary of ClinicCo, with its own HCSA licence and board. Provides liability ring-fencing and site-level P&L clarity, at higher setup cost per site.
Franchise Fee A one-time fee (per site, in the franchise model) paid by each subsidiary to ClinicCo for brand licensing, central protocols, and shared-services access. Treated as part of CapEx per site in the model.
Asymmetric Capital Where GP+ contributes less than its proportional 60% share of ClinicCo's total capital requirement. Equity stake (60%) and cash contribution become misaligned, requiring a formal resolution mechanism in the JV Agreement.
GP+ Capital Mode The three ways GP+ may contribute its capital stake in the model. Auto (Proportional) — GP+ cash is automatically calculated as 1.5× AUPE's injection. Custom — GP+ sets its own cash amount independently. In-kind — GP+ contributes no cash; its stake is represented by a formally valued non-cash contribution (brand, clinical governance, GP+ programme access).
In-kind Contribution A non-cash contribution by GP+ to ClinicCo, representing the value of the GP+ brand, clinical governance infrastructure, HCSA-compliant protocols, GP+ programme access, and Healthier SG enrolment relationships. Must be independently appraised and formally documented in the JV Agreement. Does not fund CapEx — additional cash or debt is needed to cover the capital gap.
Earn-in Structure An arrangement where GP+ begins with a smaller effective equity stake and progressively acquires its full 60% shareholding over time, funded from clinic profits rather than upfront cash. AUPE holds a temporarily higher effective stake in the early years. The earn-in schedule and buy-in price must be fixed in the JV Agreement at inception.
Capital Imbalance The difference between GP+'s actual contribution and its proportional share of total capital. GP+ Actual − (AUPE Injection × 60÷40) A negative value means GP+ is under-contributing; a positive value means GP+ is contributing more than its proportional share, strengthening CapEx coverage.
Debt / Funding Gap The shortfall between total cash available (AUPE injection + GP+ cash) and total CapEx required. Total CapEx − Total Cash Available A gap must be funded by a bank loan, MOHH facility, or phased clinic opening. The model flags this automatically when GP+ contributes below its proportional share.
Total Cash Available The sum of AUPE's capital injection and GP+'s actual cash contribution. In-kind contributions are excluded because they do not provide spendable funds for fit-out, equipment, or working capital. AUPE Injection + GP+ Cash
COOP Act Co-operative Societies Act (Cap. 62), Singapore. Governs cooperative formation, membership, surplus distribution rules (s.66), share capital interest cap (s.45, max 8% p.a.), and statutory reserve (s.65, min 20%).
HCSA Healthcare Services Act 2020. Requires ClinicCo to hold a licence for General Medical Practice (Outpatient) at each premises. Designates a Responsible Person personally accountable to MOH for clinical standards.

02 Financial Metrics

Consultation Revenue Income from patient fees: self-pay, Medisave claims, and CHAS subsidies. GPs × Sessions/wk × 52 × Avg $/session
HS Capitation Healthier SG capitation revenue. A fixed annual payment per rostered patient from MOH, independent of how frequently that patient consults. Rostered patients × $/patient/yr
Rostered Patients Residents formally enrolled with the clinic under the Healthier SG programme. Each rostered patient generates capitation income and forms the basis of the clinic's chronic disease management obligations.
OpEx Operating Expenditure. All annual running costs: lease, staffing, medications, administration, insurance/PII, and other expenses. Subtracted from revenue to arrive at EBITDA.
EBITDA Earnings Before Interest, Tax, Depreciation and Amortisation. The clinic's core operating profit before financial charges and tax. Revenue − OpEx
EBITDA Margin EBITDA as a percentage of total revenue. Measures operational efficiency. A margin below 10% indicates the model is under financial stress at current parameters.
Corporate Tax Singapore corporate income tax levied on ClinicCo's taxable profit. Standard rate: 17%. Applied to EBITDA in the model (simplified — depreciation and interest deductions not separately modelled).
Net Profit Profit after deducting OpEx and corporate tax. The starting point for the surplus distribution waterfall. EBITDA × (1 − Tax Rate)
CapEx Capital Expenditure. One-time costs to open each clinic: fit-out, medical equipment, IT systems, and initial working capital. Not in the P&L — funded by the capital injections of GP+ and AUPE. (Fit-out + Working Capital) × Sites
Distributable Surplus The net profit available to split between GP+ and AUPE after mandatory deductions. Net Profit − Statutory Reserve − Share Capital Interest
Statutory Reserve A mandatory allocation of at least 20% of annual net surplus to a reserve fund, required under COOP Act s.65. This amount cannot be distributed — it builds the cooperative's financial resilience over time.
ROI Return on Investment. AUPE's annual return expressed as a percentage of its total capital injection. Annual Return ÷ Capital Injected × 100
Payback Period The number of years for AUPE's cumulative annual returns to equal its original capital injection. Capital Injected ÷ Annual Return Shown in years or months.
Capital Gap The shortfall between AUPE's capital injection and AUPE's required 40% share of total CapEx. A gap means additional debt, grants, or phased opening is required. A negative gap (buffer) means injection exceeds CapEx requirement.

03 Return Model Terms

Pure Equity AUPE receives 40% of all distributable surplus as a dividend — proportional to its shareholding, with no floor or preference. Simple and standard, but AUPE earns nothing if the clinic is unprofitable.
Preferred Return AUPE receives a fixed preferred dividend (set as % of capital, e.g. 6% p.a.) before any surplus is shared with GP+. After the preferred dividend is paid, residual surplus is split 60/40. Gives AUPE a minimum return floor.
Preferred Rate The annual percentage dividend guaranteed to AUPE on its capital before GP+ receives any surplus. Set in the sidebar. Under Companies Act s.64, preference shares must be clearly defined in ClinicCo's constitution.
Hybrid Loan + Equity AUPE's capital is split between a shareholder loan (earning fixed interest, deductible by ClinicCo as an expense) and an equity portion (earning proportional surplus). Provides the most predictable return for AUPE.
Loan Proportion The percentage of AUPE's total capital structured as a shareholder loan rather than equity. A higher proportion increases certainty of return but reduces AUPE's equity upside. IRAS transfer pricing rules apply — loan must be at arm's length.
Loan Interest Rate The annual interest rate on the shareholder loan. Treated as an operating expense for ClinicCo (reducing taxable profit — a tax efficiency advantage). Uncapped, unlike COOP Act share capital interest (max 8%).
Revenue Share AUPE receives a fixed percentage of ClinicCo's gross revenue, paid regardless of profitability. Predictable but creates misaligned incentives — if margins are thin, the revenue share may exceed net profit, making the structure loss-making for GP+.
Revenue Share % The percentage of total gross clinic revenue paid to AUPE. A rate of 5% on a $500K revenue clinic yields $25K p.a. to AUPE. SMC ECEG review recommended to ensure this is not characterised as fee-splitting.

04 Governance & Decision-Making

Tier 1 Decision Clinical governance — GP+ sole authority. AUPE has no vote. Covers: RP designation, clinical protocols, GP member admission and expulsion, HCSA compliance, and medication formulary.
Tier 2 Decision Operational and commercial — ClinicCo Board. Requires 4 of 6 directors (GP+ nominates 4, AUPE nominates 2). Covers: annual budget, vendor contracts >$50K, fee schedules, staffing, and dividend declarations.
Tier 3 Decision Financial and structural — special majority (75%). Both cooperatives must effectively agree. Covers: changes to the 60/40 split, new clinic sites, borrowing above threshold, dissolution, and amendments to the JV Agreement.
Responsible Person A registered medical practitioner designated under HCSA s.8 who is personally accountable to MOH for clinical standards at the licensed clinic. Must be SMC-registered and directly involved in clinic management. Appointed solely by GP+.
Nominee Director A director appointed to the ClinicCo board by a shareholder cooperative. GP+ nominates 4 directors; AUPE nominates 2. Total board: 6. AUPE's nominees cannot hold the role of RP or chair the Clinical Governance Committee.
Quorum The minimum attendance for a valid board meeting. Recommended: 4 of 6 directors, including at least 2 GP+ nominees. This prevents AUPE's nominees from convening a meeting without GP+ representation.
Special Majority A vote requiring 75% shareholder approval, used for Tier 3 structural decisions. With a 60/40 split, GP+ alone cannot pass a special resolution — both cooperatives must effectively agree (60% + ≥15% of AUPE's 40%).
Casting Vote The Chairperson's right to cast a second, deciding vote in the event of a tied board vote. The Chairperson is appointed by GP+, ensuring GP+ retains practical control of tied operational decisions.

05 Healthcare Regulatory

HCSA Licence A licence issued by MOH under the Healthcare Services Act 2020 authorising a specific healthcare service at a specific premises. ClinicCo holds a licence for General Medical Practice (Outpatient) at each clinic site.
Healthier SG A national MOH programme that enrols Singapore residents with a chosen GP for holistic, prevention-focused primary care. Enrolled residents are "rostered patients" and generate capitation income for the clinic.
CHAS Community Health Assist Scheme. A MOH subsidy programme for lower- and middle-income patients at enrolled GP clinics. ClinicCo must register as a CHAS panel clinic. CHAS subsidies are included in consultation revenue.
PCN Primary Care Network. A group of GP clinics collaborating on chronic disease management and population health, supported by MOHH funding and care coordinator resources. GP+ clinic participation is expected for the full GP+ programme benefits.
SMC Singapore Medical Council. The statutory board that registers and disciplines medical practitioners in Singapore under the Medical Registration Act (Cap. 174). All GPs practising at ClinicCo must hold valid SMC registration.
PII Professional Indemnity Insurance. Insurance covering claims of clinical negligence against practitioners. Required for all GPs under SMC guidelines. The model includes group PII as an annual operating cost for ClinicCo.

06 Clinic Operations — Sidebar Inputs

GPs per Site The number of General Practitioners practising at a single clinic location. This is the primary driver of consultation revenue volume and total session capacity. Typical GP+ clinic: 3–6 GPs per site.
Sessions / GP / wk The number of consulting sessions each GP works per week. A standard full-time GP runs approximately 35–45 sessions per week. Each session is approximately 10–15 minutes of patient contact time.
Avg $ per Session The average revenue earned per patient consultation, blended across self-pay, Medisave, and CHAS rates. Typical range for a Singapore GP clinic: $30–$70 per session depending on patient mix and service complexity.
HS Capitation ($/pt) The annual Healthier SG capitation payment per rostered patient. Set by MOH and payable regardless of consultation frequency. This input allows modelling of different subsidy rate scenarios. Current indicative rate: ~$80–$120 per patient per year.
Clinic Phase The selected expansion stage in the model. Short Term (1–3 sites), Mid Term (3–10 sites), Long Term (25+ sites). Switching phase changes the site count used in all network-level calculations.
Capital Injection AUPE's total capital contributed to ClinicCo. Toggleable at $50K, $100K, $200K, or $500K. GP+'s capital is calculated proportionally as Injection × (60 ÷ 40). Together they form the total available capital to fund CapEx.